Abstract
Noninvasive ventilation (NIV) is a standard of care for the treatment of exacerbation of chronic obstructive pulmonary disease, to prevent intubation and reduce morbidity and mortality. The need for humidification of NIV gas is controversial. Some unique aspects of NIV conspire to alter the delivered humidity and airway function. In the presence of air leaks, unidirectional air flow dries the airways and increases airway resistance. Patient comfort is also a critical issue, as tolerance of NIV is often tied to patient comfort. This paper provides the arguments for and against routine humidification during NIV in the hospital setting. Data from clinical research demonstrate the effects of delivered humidification on relevant physiologic variables. The impact of humidification on NIV success/failure remains speculative.
Footnotes
- Correspondence: Richard D Branson MSc RRT FAARC is affiliated with the Department of Surgery, University of Cincinnati Medical Center, PO Box 670558, 231 Albert Sabin Way, Cincinnati OH 45267-0558. E-mail: richard.branson{at}uc.edu.
Mr Branson and Mr Gentile presented a version of this paper at the 44th Respiratory Care Journal Conference, “Respiratory Care Controversies II,” held March 13-15, 2009, in Cancún, Mexico.
Mr Branson has disclosed relationships with Ikaria, Bayer, Newport, CareFusion, and Covidien. Mr Gentile has disclosed no conflicts of interest.
↵* Ulf Börg, Covidien, Boulder, Colorado.
- Copyright © 2010 by Daedalus Enterprises